Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Zenas Biopharma Inc (ZBIO)

Zenas Biopharma Inc (ZBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Zenas Biopharma Inc 852 Winter Street Suite 250 Waltham MA 02451 USA

www.zenasbio.com Employees: 130 P: 857-271-2954

Sector:

Medical

Description:

Zenas BioPharma Inc. is a clinical-stage global biopharmaceutical company. It involved in the development and commercialization of transformative immunology-based therapies for patients in need. The company's lead product candidate includes obexelimab and Fc'RIIb. Zenas BioPharma Inc. is based in WALTHAM, Mass.

Key Statistics

Overview:

Market Capitalization, $K 2,049,196
Enterprise Value, $K 1,729,366
Shares Outstanding, K 53,679
Annual Sales, $ 5,000 K
Annual Net Income, $ -156,990 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -52,220 K
EBIT, $ -194,090 K
EBITDA, $ -193,950 K
60-Month Beta -1.61
% of Insider Shareholders 16.50%
Float, K 44,822
% Float 83.50%
Short Volume Ratio 0.42

Growth:

1-Year Return 311.58%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.22 on 11/12/25
Next Earnings Date 02/11/26
Earnings Per Share ttm -7.07
EPS Growth vs. Prev Qtr 2.40%
EPS Growth vs. Prev Year 75.70%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Next Ex-Dividends Date 12/24/19
Dividend Payable Date 01/02/20
Dividend Payout Ratio 0.00%

ZBIO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -73.55%
Return-on-Assets % -57.60%
Profit Margin % -3,139.80%
Debt/Equity 0.00
Price/Sales 422.61
Price/Cash Flow N/A
Price/Book 8.44
Book Value/Share 5.73
Interest Coverage -4.26
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar